Environmental Health Tracking and Biomonitoring Program
Advisory Panel Meeting Agenda
for February 11, 2014: 1:00 – 4:00 pm
at The American Lung Association in Minnesota
490 Concordia Avenue, St. Paul, Minnesota
Time
Agenda Items
Presenters
Description/expected outcome
1:00
Welcome &
Introductions
Patricia
McGovern,
Chair
Panel members & audience are invited to
introduce themselves
1:05
Tracking Updates
Jean Johnson
•
•
•
Governor’s award
New portal content
CDC projects update
Chuck Stroebel
Information item: Jean will give a brief
review of MN Tracking program updates.
Panel members are invited to ask questions
or comment on updates.
1:10
Advancing Health Equity
and Portal Data
Demonstration
Chuck Stroebel
1:30
Discussion
Discussion Item: MDH will present an
overview of the agency’s health equity
initiative. Chuck will highlight data on the
portal that reveals health disparities and
sub-county level data.
Questions for the panel:


1:50
New Pesticide Poisoning
Data Demonstration
2:05
Refreshments
2:15
2:25
Over the next 3-5 yrs, how could data
on the portal be enhanced to inform
actions that advance health equity?
Over the next 3-5 yrs, what could the
biomonitoring program be doing to
inform actions that advance health
equity and environmental justice?
Tess Konen
Information item: Tess will give a brief
preview of new Tracking pesticide
poisoning data. Panel members are invited
to ask questions or provide comment.
East Metro PFC3
Biomonitoring Project
Update
Christina
Rosebush
Information item: Christy will present the
status of the PFC3 project. Panel members
are invited to ask questions or comment.
Biomonitoring Updates
Paul Moyer,
Information item: Jessica and Paul will
Time
Agenda Items
2:40
Newborns’
Biomonitoring Protocol:
Community Selection
3:00
Discussion
Presenters
Description/expected outcome
Public Health
Laboratory
Jessica Nelson
briefly describe recent status of metals
projects and laboratory. Panel members
are invited to ask questions or comment.
Jessica Nelson
Discussion Item: Jessica will review the
draft protocol and rationale for the
community selection and consent process
that is proposed.
Questions to the panel:




3:30
Sustaining Minnesota
Biomonitoring:
Workgroup Progress
Report
3:40
Discussion
Kristin Van
Amber
Discussion item: Kristin will report on the
first 2 meetings of the Sustaining
Minnesota Biomonitoring Workgroup, draft
charter and work plan.
Questions to the panel:


3:50
New Business
3:55
Audience Questions
4:00
Motion to adjourn
Does the panel agree with the
proposed clinic-based community
selected for this project?
How might we might best engage the
community, and recruit participants?
Should enrollment be open to all
women seen for prenatal care in the
community clinics, or should eligibility
be further limited by race/ethnicity?
Given that urine is a better biomarker
for inorganic mercury found in skinlightening creams, should we also
collect a maternal urine sample?
Does the charter and plan fit with your
understanding of the group’s charge?
What suggestions do you have to assist
them in developing an action plan for
sustaining Minnesota Biomonitoring?
Note to audience: The panel asks that audience members hold comments and questions on discussion
items until the end of the meeting, when the chair will invite questions from the audience. Audience
members are asked to identify themselves when they speak, and to please record their names and
affiliations on the list at the sign-in table. Meetings are recorded on audiotape.